Corient Private Wealth’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.11M Sell
127,722
-132,352
-51% -$4.9M 0.01% 925
2025
Q4
$10.9M Buy
+260,074
New +$10.5M 0.01% 746
2025
Q3
Sell
-127,899
Closed -$3.46M 2688
2025
Q2
$3.46M Buy
127,899
+60
+0% +$1.74K ﹤0.01% 827
2025
Q1
$3.79M Buy
127,839
+6,594
+5% +$251K 0.01% 760
2024
Q4
$4.8M Sell
121,245
-11,545
-9% -$437K 0.01% 711
2024
Q3
$4.52M Buy
132,790
+69,139
+109% +$1.95M 0.01% 782
2024
Q2
$1.38M Sell
63,651
-489
-0.8% -$10.3K ﹤0.01% 1195
2024
Q1
$1.42M Buy
64,140
+362
+0.6% +$8.83K ﹤0.01% 1186
2023
Q4
$1.75M Buy
63,778
+3,696
+6% +$89.2K ﹤0.01% 1063
2023
Q3
$1.34M Buy
60,082
+82
+0.1% +$2.11K ﹤0.01% 1081
2023
Q2
$1.53M Sell
60,000
-12
-0% -$291 ﹤0.01% 991
2023
Q1
$1.34M Hold
60,012
﹤0.01% 981
2022
Q4
$1.42M Buy
+60,012
New +$1.39M 0.01% 808

Other funds holding VCYT

Corient Private Wealth's VCYT Position: Q1 2026 in Review

Corient Private Wealth reduced its Veracyte (VCYT) stake by 51% in Q1 2026, selling an estimated $4.9M and leaving 127,722 shares worth $4.11M. The position accounts for 0.01% of the portfolio, ranked #925.

Corient Private Wealth first reported a position in VCYT in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.9M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Corient Private Wealth held 127,722 shares of Veracyte worth $4.11M as of Q1 2026.
  • Corient Private Wealth sold 132,352 Veracyte shares in Q1 2026, an estimated $4.9M.
  • Veracyte made up 0.01% of Corient Private Wealth's portfolio in Q1 2026, its #925 holding.
  • Corient Private Wealth first reported a position in Veracyte in Q4 2022 and has held it in 13 quarters since.
  • Corient Private Wealth's Veracyte position peaked at $10.9M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.